Site visits involved a team of 2-5 staff who visited each site for 2 days to observe the setting, speak with program staff, and conduct qualitative interviews with Principal Investigators, program administrators, medical directors, nursing and counseling staff, doctors prescribing bup/nx, and any other personnel involved in providing bup/nx-related care.